Paradigm Health Acquires Flatiron Health's Clinical Research Business

December 4, 2025

Paradigm Health has acquired Flatiron Health’s Clinical Research Business and entered a multi-year strategic partnership to integrate Flatiron’s research network and solutions with Paradigm’s AI-powered trial platform. The deal expands Paradigm’s oncology research network to include more academic medical centers and nearly 100 community oncology practices, increasing access to clinical trials across the United States; terms were not disclosed.

Buyers
Paradigm Health, Inc.
Targets
Flatiron Health's Clinical Research Business
Sellers
Flatiron Health
Location
New York, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.